Бронза Медыцынскі прадукт · 2024
Smarthaler Разумны дазаваны інгалятар
by Jacek Mikosz
- Бронзавая прэмія A' Design Award 2024 in Медыцынскі прадукт
- CLIENT: FindAir
- Estimated Number of Design Views: 50,290
- Verification code 47C73ADE59 · Verify this award
Colors
About Smarthaler Разумны дазаваны інгалятар
Smarthaler - гэта лічбавы дазаваны аэразольны інгалятар, які выкарыстоўвае аналіз на аснове штучнага інтэлекту ў рэжыме рэальнага часу і збор даных для дапамогі пацыентам з астмай і ХАБЛ у асваенні правільнай тэхнікі інгаляцыі і паляпшэнні асаджэння лекавага сродку. Яго модульны дызайн уключае прасунутыя алгарытмы вызначэння патоку, што дазваляе яму працаваць як стандартны інгалятар, адначасова прапаноўваючы дадатковую перавагу ў выглядзе шматразовага электроннага модуля, прымацаванага да задняй часткі аэразольнага дыспенсера. Пасля кожнага выкарыстання ён забяспечвае імгненную зваротную сувязь аб якасці інгаляцыі. Гэтыя даныя адпраўляюцца ў мабільны дадатак для неадкладнага абмену з урачамі або камандамі па догляду, што спрыяе больш якаснаму догляду.
About the Бронзавая прэмія A' Design Award
Smarthaler Разумны дазаваны інгалятар — пераможца Бронзавай прэміі A' Design Award, высокапрэстыжнага прызнання, якое прысуджаецца выдатным дызайнам, што вылучаюцца творчасцю, вынаходлівасцю і праніклівасцю. Бронзавыя пераможцы — гэта ўмелыя і ўражліва творчыя артэфакты, якія пацвярджаюць вялікі вопыт, уяўленне і знаходлівасць сваіх дызайнераў. Чакаецца, што Smarthaler Разумны дазаваны інгалятар — гэта высока цэнены, захапляльны і любімы прадмет, надзвычай прафесійны і інавацыйны. Гэты дызайн, што атрымаў Бронзавую прэмію A' Design Award, уключае лепшыя практыкі ў мастацтве, навуцы, дызайне і тэхналогіях і выдатны ўвагай да дэталей. Smarthaler Разумны дазаваны інгалятар цудоўна задавальняе патрэбы, кранае жаданні, зачароўвае пачуцці і ўзбуджае цікаўнасць.
Press Kit
- Unique Properties
- The modular smart inhaler device features a measurement system that enables real-time identification and correction of inhalation errors, enhancing the effectiveness of drug delivery without disrupting the inhalation process. Integrating a verification system directly into the actuator's design, ensures patients can more efficiently and effectively adhere to prescribed therapies while developing correct inhalation techniques habits. Information is sent to an app, where it can also be shared.
- Dimensions & Packaging
- Device Dimensions: 29,7 mm x 57 mm x 93 mm
Packaging Dimension: 107 mm x 40 mm x 140 mm
Material: PP/ABS
Battery: Rechargeable
Port type: USB-C
Connection: Bluetooth Low Energy
Compatible Apps: FindAir Smarthaler (Android/iOS), FindAir Doctor Web App
Accessories:
USB Hub that enables using it without the phone
HFA Placebo Bottles
Additional Actuators - Tags
- smart inhaler, iot, medical device, modular, digital health, telemedicine, education, pMDI, inhaler, inhaler technique
- Production Technology
- The solution results from extensive user research, clinical trials, and data collection from patients and medical professionals. It represents a multidisciplinary collaboration, combining expertise from design, medical, IT, artificial intelligence, and pharmacokinetics fields. The device's electronics integration within a medical-grade plastic enclosure employs precision injection molding rigorously tested and validated through lab-based pharmacokinetic studies to ensure durability and safety.
- Design Challenge
- The primary challenge was integrating advanced technology into a design as familiar as a traditional pMDI inhaler, ensuring it was approachable yet innovative. Our objective was for users to adopt this advanced inhaler as naturally as they would their standard one, but with added functionalities for a richer experience. Developing a modular design was crucial to allow for the sustainable use of electronic components, enabling users to update or replace parts without discarding the entire device.
- Research
- Research aimed to refine pmdi inhaler experience, employing a mixed-method approach. We conducted medical experiments, and observational studies complemented by desk research to gather base data and validate it in clinical trials, and lab tests. Using custom measurement setups and digital tools, we gathered data from a diverse group of patients and healthcare professionals. The findings emphasized the need for modular, intuitive inhalers that improve user inhaler technique and treatment efficacy.
- Inspiration
- The inspiration for the device emerged from observing close relatives struggle with conventional inhalers during asthma attacks, leading to insufficient relief despite multiple inhaler usage attempts. This prompted a deeper investigation into inhalation techniques research, revealing that 83,7% of users exhibit incorrect usage, primarily due to the complex coordination required by inhalers. The sequential motion set (precise timing, strength, and duration) presents a significant challenge.
- Project Duration
- Project started May 2021 in (Kraków, Poland) and finished in December 2023 (Kraków, Poland) as part of FindAir research supported by a grant received from The National Centre for Research and Development.
- Operation Flow
- The inhaler functions like a regular inhaler but with an added feature: an electronic module that fits onto the back. This module is optional, allowing the inhaler to be used in its basic form or enhanced with digital feedback. After using the inhaler, users receive immediate feedback on how well they inhaled the medication. This information is sent directly to an app, where it can also be shared instantly with a doctor. The device serves dual purposes: delivering medication, or training tool.
- Patents
- Copyrights belong to FindAir Sp. z o.o, 2024.
Smarthaler® - Registred EUIPO trademark
EU patent filling:
EP22461546.8 – AN ACTUATOR FOR AN INHALER
EP22461592.2 – A DEVICE FOR MONITORING USE OF AN INHALER
EP3856305 – METHOD FOR MONITORING DRUG INTAKE - Image Credits
- FindAir Sp. z o.o. Internal Materials
